Escitalopram Tablet, Film Coated
Product Images NDC 65862-375

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Escitalopram (NDC 65862-375). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label-principal Display Panel (5 mg (100 Tablet Bottle))

Package Label-principal Display Panel (5 mg (100 Tablet Bottle))
Escitalopram Tablets USP 5 mg film-coated tablet label by Aurobindo Pharma Limited. The label states the active ingredient as Escitalopram oxalate USP equivalent to 5 mg escitalopram base. It indicates the product is for prescription use only and comes in a package of 100 tablets. Directions include storage instructions and a note to see the package insert for dosage information. The label also includes the distributor's address in East Windsor, NJ, and states the product is made in India.*
FDA Label Image

Package Label-principal Display Panel (5 mg Blister Carton (10 x 10 Unit-dose))

Package Label-principal Display Panel (5 mg Blister Carton (10 x 10 Unit-dose))
Box packaging label for Escitalopram Tablets USP 5 mg film-coated unit-dose tablets by Aurobindo Pharma Limited. The label indicates 100 tablets (10 x 10 unit-dose) per box and includes dosage strength, NDC code 65862-373-10, and dispensing instructions. The label features the Aurobindo logo and dosage form details prominently.*
FDA Label Image

Package Label-principal Display Panel (10 mg (100 Tablet Bottle))

Package Label-principal Display Panel (10 mg (100 Tablet Bottle))
Label for Escitalopram 10 mg film-coated tablets by Aurobindo Pharma Limited. The label includes dosage strength, quantity of 100 tablets, storage instructions, and distributor information. The product is indicated as Rx only and lists the NDC code 65862-374-01.*
FDA Label Image

Package Label-principal Display Panel (20 mg Blister Carton (10 x 10 Unit-dose))

Package Label-principal Display Panel (20 mg Blister Carton (10 x 10 Unit-dose))
Escitalopram Tablets USP 10 mg film-coated tablets box from Aurobindo Pharma Limited. The packaging is for 100 unit-dose tablets (10 x 10) with clear labeling of the generic name, strength, and dosage form. The carton includes barcode details and dispensing information for pharmacists.*
FDA Label Image

Figure5 (Escitalopram Fig5)

Figure5 (Escitalopram Fig5)
Label for Escitalopram Tablets USP 20 mg film-coated tablets. The label indicates the product is prescription only, distributed by Aurobindo Pharma USA, Inc., and manufactured in India by Aurobindo Pharma Limited. The package contains 100 tablets, with storage and dispensing instructions included. The NDC code is 65862-375-01.*
FDA Label Image

Figure6 (Escitalopram Fig6)

Figure6 (Escitalopram Fig6)
Packaging label for Escitalopram Tablets USP, 20 mg film-coated tablets by Aurobindo Pharma Limited. The label indicates the prescription status (Rx only) and package size of 100 unit-dose tablets (10 x 10). The design features the product name, strength in orange ovals, NDC 65862-375-10, and instructions to dispense with a medication guide. Aurobindo's logo is displayed.*
FDA Label Image

Chemical Structure (Escitalopram Str)

Chemical Structure (Escitalopram Str)
Chemical structure diagram of Escitalopram Oxalate, showing atomic connectivity including a cyanide (NC) group, fluorophenyl ring, methylated amine side chain, and oxalate moiety as indicated by the formula C2H2O4 beside the structure.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.